Institute for International Research

Know how to achieve

Main menu

My IBC

Login form

Sign Up

Home»Events»Cell Line Development...Event Overview»Scientific Advisory Committee & Distinguished Faculty

Cell Line Development and Engineering Cell Line Development and Engineering

Event Information

Increasing Expression, Quality and Understanding while Shortening Development Lead Times through Total Process Optimization
June 23 - 25, 2008 · Hilton San Diego Resort · San Diego, CA

Document Title

Scientific Advisory Committee & Distinguished Faculty

Scientific Advisory Committee & Distinguished Faculty

Scientific Advisory Committee

  • Laurie Donahue-Hjelle, Ph.D., Director of Cell Line Development, Invitrogen Corporation
  • Stefanos Grammatikos, Ph.D., Director Upstream Development, Biopharmaceutical Process Science, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
  • John Joly, Ph.D., Director of Early Stage Cell Culture, Process Development, Genentech, Inc.
  • Kevin J. Kayser, Ph.D., Research and Development Manager, Cell Line Engineering, SAFC Biosciences
  • Dennis M. Kraichely, Ph.D., Principal Research Scientist, Expression Technologies, Centocor, Inc.
  • Mark D. Moody, Ph.D., Senior Director, Quality Control/Formulation, Merrimack Pharmaceuticals, Inc.
  • John Mott, Ph.D., Director, Bioprocess R&D, Cell Line Development, Pfizer Global Biologics
  • Bernhard O. Palsson, Ph.D., Professor of Bioengineering, University of California, San Diego
  • Morris Rosenberg, D.Sc., Senior Vice President, Development, Seattle Genetics

Distinguished Faculty

  • Ashraf Amanullah, Ph.D., Genentech, Inc.
  • Robert Babb, Ph.D., Regeneron Pharmaceuticals, Inc.
  • Ben Bowen, Ph.D., Biolog
  • Michael Butler, Ph.D., University of Manitoba, Canada
  • Frank Carr, Ph.D., Antitope Ltd, United Kingdom
  • Trevor Collingwood, Sangamo BioSciences Inc.
  • Kevin Cox, MS, Biolex Therapeutics
  • Keith A. Davis, Ph.D., Pfizer Inc
  • Alan J. Dickson, Ph.D., University of Manchester, United Kingdom
  • Laurie Donahue-Hjelle, Ph.D., Invitrogen Corporation
  • Yves Durocher, Ph.D., National Research Council of Canada
  • Sybille S. Galosy, Ph.D., Pfizer Inc
  • Philip D. Gregory, Ph.D., Sangamo BioSciences Inc.
  • Christopher Hatfield, Eli Lilly and Company
  • Diane Hatton, Ph.D., MedImmune Limited, United Kingdom
  • David James, University of Sheffield, United Kingdom
  • Roy Jefferis, Ph.D., University of Birmingham, United Kingdom
  • Nigel Jenkins, University College Dublin, Ireland
  • John Joly, Ph.D., Genentech, Inc.
  • Britta Krampe, Ph.D. Student, University College Dublin, Ireland
  • Viswanatham Katta, Genentech, Inc.
  • Randal J. Kaufmann, Ph.D., University of Michigan Medical Center
  • Kevin J. Kayser, Ph.D., SAFC Biosciences
  • Dennis M. Kraichely, Ph.D., Centocor, Inc.
  • Deborah Lee Dormady Letham, Ph.D., Charles River Laboratories
  • Gyun Min Lee, KAIST, Korea
  • Peggy Lio, Invitrogen Corporation
  • Paula Meleady, Ph.D., Dublin City University, Ireland
  • Mark Melville, Ph.D., Wyeth BioPharma
  • Michael Milburn, Ph.D., Metabolon
  • John Mott, Ph.D., Pfizer Global Biologics
  • Nels Pederson, Ph.D., Biogen Idec
  • Genova Richardson, SAFC Biosciences
  • Morris Rosenberg, D.Sc., Seattle Genetics
  • Richard Schoenfeld, Ph.D., BioWorks Consulting
  • Torsten W. Schulz, Ph.D., Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
  • Amy Shen, Genentech, Inc.
  • Jose Varghese, Merrimack Pharmaceuticals
  • Andy Walker, Ph.D., ICOS Biologics
  • Stefan Wildt, Ph.D., Merck & Co., Inc.
  • Jianguo Yang, Ph.D., MedImmune, Inc.
  • Lin Zhang, Pfizer Inc

Bottom menu

Copyright IBC Life Sciences, a part of Informa Life Sciences Group

Powered by Interactive Agency Janmedia Interactive, Inc.